This launch is intended to help determine the efficacy of repurposed, previously approved drugs for other conditions in hopes of identifying drug candidates for additional study. However, the implications reach...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)